Skip to main content
NVDA-1.92%AAPL+1.34%GOOGL+0.21%MSFT-0.63%AMZN-0.92%TSM-1.79%SPCX-1.90%META-2.29%AVGO-1.55%TSLA-2.02%LLY+3.71%BRK-B-0.11%SKHY-3.52%MU-1.40%AMD-3.52%WMT+1.61%JPM+0.56%V-0.85%XOM+0.72%ASMLa+2.03%JNJ+1.24%MA-0.32%INTC-2.55%ABBV+2.97%0700.HK-0.42%1398.HK-0.92%CSCO+0.69%CVX+1.05%COST+1.20%KO+0.70%ORCL-7.40%PG+1.05%LRCX-2.73%AMAT-2.05%AP2d+0.34%UNH+2.83%BAC-7.66%DELL-7.63%CAT-1.55%1816.HK+2.71%3988.HK-1.12%0005.HK-1.79%0857.HK+1.17%HSBA.L-1.43%GE+0.76%PM+1.64%0939.HK-1.00%1288.HK-2.23%NFLX-0.52%HD-1.10%USDMXN+1.03%USDSEK+0.95%USDCHF+0.93%CADCHF+0.76%USDZAR+0.73%AUDCHF+0.70%EURUSD-0.66%USDPLN+0.64%USDDKK+0.63%EURHKD-0.62%CHFJPY-0.62%GBPCHF+0.57%NZDUSD-0.56%EURCNH-0.54%EURCAD-0.50%USDSGD+0.49%USDTHB+0.47%NZDMXN+0.43%NZDCAD-0.42%EURAUD-0.42%GBPTRY+0.41%AUDDKK+0.40%USDNOK+0.37%GBPUSD-0.37%AUDNZD+0.36%EURJPY-0.35%PLNJPY-0.34%NZDCHF+0.34%GBPHKD+0.32%EURSEK+0.32%CHFSEK+0.31%USDJPY+0.30%GBPMXN-0.28%USDTRY+0.28%NZDJPY-0.28%EURGBP-0.27%CHFNOK-0.27%EURCHF+0.26%EURNOK-0.26%AUDSGD+0.25%AUDUSD-0.23%GBPNZD+0.19%SGDJPY-0.19%GBPZAR+0.19%GBPCAD-0.18%USDCAD+0.18%USDILS+0.16%EURSGD-0.14%CHFSGD-0.14%GBPAUD-0.13%AUDNOK+0.12%CADJPY+0.11%EURZAR+0.11%NZDSGD-0.11%USDCNH+0.08%GBPJPY-0.08%NOKJPY-0.07%AUDJPY+0.07%EURNZD-0.05%GBPSGD-0.05%AUDCAD-0.04%USDCOP-0.04%EURCZK+0.04%EURPLN+0.01%USDHKD+0.01%EURDKK+0.01%XAGUSD-4.86%GAGUSD-4.85%XPTUSD-2.69%XNGUSD-2.62%COFFEE+2.33%XAUUSD-1.53%GAUUSD-1.52%COCOA+0.75%COTTON+0.56%S1-0.53%SUGAR-0.52%HG1-0.41%BTCUSD-1.39%ETHUSD+15.24%USDTUSD0.00%XRPUSD+9.86%SOLUSD+10.90%TRXUSDT+1.88%ZECUSDT-4.04%DOGEUSD+11.12%XMRUSDT+0.54%LINKUSD+11.09%XLMUSD-3.42%BCHUSDT-1.61%UNIUSD-4.58%LTCUSD+9.37%SUIUSD-3.12%HBARUSDT-3.32%TONUSD+24.80%TAOUSDT-3.21%AAVEUSD-2.62%DOTUSDT-2.86%ICPUSDT-3.47%ONDOUSDT-4.74%WLDUSDT-5.00%ARBUSDT-5.22%JUPUSDT-4.07%ATOMUSDT-4.68%INJUSDT-3.72%STXUSDT-2.17%FETUSDT-3.31%PYTHUSDT+5.88%TIAUSDT-5.18%SEIUSDT-3.09%IMXUSDT-5.36%OPUSDT-10.56%GRTUSDT-3.79%WIFUSDT-3.70%IOTAUSDT-5.32%AXSUSDT-4.62%POLUSDT-4.91%EOSUSDT+3.99%FARTCOINUSDT-5.10%DYDXUSDT-5.74%GALAUSDT-5.44%ORDIUSDT-4.32%RONINUSDT-7.27%NOTUSDT-5.58%NVDA-1.92%AAPL+1.34%GOOGL+0.21%MSFT-0.63%AMZN-0.92%TSM-1.79%SPCX-1.90%META-2.29%AVGO-1.55%TSLA-2.02%LLY+3.71%BRK-B-0.11%SKHY-3.52%MU-1.40%AMD-3.52%WMT+1.61%JPM+0.56%V-0.85%XOM+0.72%ASMLa+2.03%JNJ+1.24%MA-0.32%INTC-2.55%ABBV+2.97%0700.HK-0.42%1398.HK-0.92%CSCO+0.69%CVX+1.05%COST+1.20%KO+0.70%ORCL-7.40%PG+1.05%LRCX-2.73%AMAT-2.05%AP2d+0.34%UNH+2.83%BAC-7.66%DELL-7.63%CAT-1.55%1816.HK+2.71%3988.HK-1.12%0005.HK-1.79%0857.HK+1.17%HSBA.L-1.43%GE+0.76%PM+1.64%0939.HK-1.00%1288.HK-2.23%NFLX-0.52%HD-1.10%USDMXN+1.03%USDSEK+0.95%USDCHF+0.93%CADCHF+0.76%USDZAR+0.73%AUDCHF+0.70%EURUSD-0.66%USDPLN+0.64%USDDKK+0.63%EURHKD-0.62%CHFJPY-0.62%GBPCHF+0.57%NZDUSD-0.56%EURCNH-0.54%EURCAD-0.50%USDSGD+0.49%USDTHB+0.47%NZDMXN+0.43%NZDCAD-0.42%EURAUD-0.42%GBPTRY+0.41%AUDDKK+0.40%USDNOK+0.37%GBPUSD-0.37%AUDNZD+0.36%EURJPY-0.35%PLNJPY-0.34%NZDCHF+0.34%GBPHKD+0.32%EURSEK+0.32%CHFSEK+0.31%USDJPY+0.30%GBPMXN-0.28%USDTRY+0.28%NZDJPY-0.28%EURGBP-0.27%CHFNOK-0.27%EURCHF+0.26%EURNOK-0.26%AUDSGD+0.25%AUDUSD-0.23%GBPNZD+0.19%SGDJPY-0.19%GBPZAR+0.19%GBPCAD-0.18%USDCAD+0.18%USDILS+0.16%EURSGD-0.14%CHFSGD-0.14%GBPAUD-0.13%AUDNOK+0.12%CADJPY+0.11%EURZAR+0.11%NZDSGD-0.11%USDCNH+0.08%GBPJPY-0.08%NOKJPY-0.07%AUDJPY+0.07%EURNZD-0.05%GBPSGD-0.05%AUDCAD-0.04%USDCOP-0.04%EURCZK+0.04%EURPLN+0.01%USDHKD+0.01%EURDKK+0.01%XAGUSD-4.86%GAGUSD-4.85%XPTUSD-2.69%XNGUSD-2.62%COFFEE+2.33%XAUUSD-1.53%GAUUSD-1.52%COCOA+0.75%COTTON+0.56%S1-0.53%SUGAR-0.52%HG1-0.41%BTCUSD-1.39%ETHUSD+15.24%USDTUSD0.00%XRPUSD+9.86%SOLUSD+10.90%TRXUSDT+1.88%ZECUSDT-4.04%DOGEUSD+11.12%XMRUSDT+0.54%LINKUSD+11.09%XLMUSD-3.42%BCHUSDT-1.61%UNIUSD-4.58%LTCUSD+9.37%SUIUSD-3.12%HBARUSDT-3.32%TONUSD+24.80%TAOUSDT-3.21%AAVEUSD-2.62%DOTUSDT-2.86%ICPUSDT-3.47%ONDOUSDT-4.74%WLDUSDT-5.00%ARBUSDT-5.22%JUPUSDT-4.07%ATOMUSDT-4.68%INJUSDT-3.72%STXUSDT-2.17%FETUSDT-3.31%PYTHUSDT+5.88%TIAUSDT-5.18%SEIUSDT-3.09%IMXUSDT-5.36%OPUSDT-10.56%GRTUSDT-3.79%WIFUSDT-3.70%IOTAUSDT-5.32%AXSUSDT-4.62%POLUSDT-4.91%EOSUSDT+3.99%FARTCOINUSDT-5.10%DYDXUSDT-5.74%GALAUSDT-5.44%ORDIUSDT-4.32%RONINUSDT-7.27%NOTUSDT-5.58%
ZB

Zimmer Biomet Holdings, Inc. (ZBH)

NYSE • Healthcare

$92.08
-$0.09 (-0.1%)
Market open

Last close at October 13, 2026 at 20:00 UTC

Open$92.87
Previous Close$92.08
Day Range$91.39 - $93.85
Avg. Volume (3M)2.2M
Market Cap$17.7B
P/E Ratio22.3
52 Week Range
$79.12$106.88
Next EarningsIn 21 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$2.1B100%
Gross Profitminus cost of goods$1.5B71%
Operating Incomeminus R&D and overhead$326.1M15%
Net Incomeminus taxes and the rest$198.3M9%

In plain terms: out of every $100 in revenue, Zimmer Biomet Holdings, Inc. keeps $9 as net profit.

Fundamentals & Financials

Revenue (TTM)
$8.5B
Net Income (TTM)
$806.8M
EPS (TTM)
$4.13
ROA (TTM)
3.54%
Current Ratio
1.69
Dividend Yield
0.28%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+1.7%Q1 2026$2.42
+12.4%Q2 2026$2.09
+3.0%Q3 2026$2.07
Next

Nov 4

in 21 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +3.0%

Zimmer Biomet Holdings beat expectations on both the top and bottom line, with second fiscal quarter of 2026 results reported on Aug. 5 showing adjusted EPS of $2.07 versus the $2.01 estimate and revenue of about $2.18 billion versus about $2.13 billion, a beat of 3% and 2%, respectively. Revenue rose 4.8% from about $2.1 billion a year ago, while gross margin held near 71% and operating margin was 15.0% as operating income reached about $326 million. Net income climbed 29.8% to about $198 million from about $153 million a year ago, and adjusted EPS was unchanged from $2.07 a year earlier. The company generated operating cash flow of about $807 million, repurchased about $500.8 million of stock, and paid about $93.4 million in dividends. Next-period consensus calls for EPS of $1.88 on revenue of $2.04 billion.

Next report — what to expect

Zimmer Biomet Holdings, Inc. (ZBH) reports earnings on November 4, 2026. Wall Street is expecting EPS of $1.88 on revenue of $2.04 billion. For trailing context, revenue grew +4.8% year over year last quarter. Zimmer Biomet has beaten EPS in 7 of 8 most recent quarters.

View full earnings history

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. designs and sells musculoskeletal and dental implants, related surgical products, and care-enabling technology as a healthcare company focused on medical devices. Its business spans reconstructive joints, trauma, spine, dental, and procedure tools, and it generated $8.2 billion of revenue in FY2025.

Name
Zimmer Biomet Holdings, Inc.
CEO
Ivan Tornos
Website
www.zimmerbiomet.com
Industry
Healthcare
Year Founded
1927
Employees
17,000

Today's Snapshot

AI-generated

ZBH closed slightly lower at 92.08. Zimmer Biomet extended its deal for the TMINI surgical robot.

Trading Volume

Above 10d avg 2.1M

2.2M

vs S&P 500 Today

Inline with Market

-0.08%

Updated: October 14, 2026 at 12:32 UTC

ZBH Headlines

Zimmer Biomet posts strong Q1, updates CFO role

April 28, 2026

4 min read

Institutions Adjust Stakes in Major U.S. Corporates

March 11, 2026

4 min read
View All News

Technical Indicators

2 Buy3 Neutral3 Sell
ZBH shows a mixed technical picture with short-term moving averages sitting below the current price while medium-to-longer averages are resisting upside, leaving price near the classic pivot. Momentum readings are mildly positive while RSI and MACD are essentially neutral, and ADX under 20 indicates little trend strength. Volatility is modest with an ATR around 2.5, and on-balance volume is tilted negative, suggesting limited conviction behind recent moves. Overall the indicators are conflicted and leaning neither strongly bullish nor bearish. Technical takeaway: Neutral — short-term strength offset by longer-term resistance and weak trend.
All signals
  • EMA (5 indicators)$90.60 - $93.08
    Sell
  • RSI (14)49.68
    Neutral
  • Stochastic %K (14, 3, 3)60.14
    Neutral
  • MACD Level (12, 26)-1.39
    Neutral

Peers & Related Assets

MDTMedtronic Plc
$92.59-0.5%
SYKStryker Corporation
$280.46-0.7%
BSXBoston Scientific Corporation
$43.31-1.2%
EWEdwards Lifesciences Corporation
$85.27-1.3%
GEHCGE HealthCare Technologies Inc.
$68.79+1.6%
ALGNAlign Technology, Inc.
$142.54-0.7%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.